Golwas Douglas P
Chief Commercial Officer
Golwas Douglas P has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 17, 2026.
On the most recent filing, Golwas Douglas P is listed as Chief Commercial Officer at Medline Inc. Inside the rolling window, Golwas Douglas P reported no open-market purchases and 1 open-market sale totaling $3.7M in MDLN.
Companies traded
Other insiders at MDLN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Golwas Douglas P made?
Golwas Douglas P has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Golwas Douglas P trade?
Golwas Douglas P has filed SEC Form 4 disclosures for 1 company, including MDLN.
When was Golwas Douglas P's most recent SEC Form 4 filing?
Golwas Douglas P's most recent SEC Form 4 filing on Tracefour is dated Jun 17, 2026.
What is Golwas Douglas P's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Golwas Douglas P is listed as Chief Commercial Officer.
What is Golwas Douglas P's total buy and sell value in the current window?
Inside the rolling retention window, Golwas Douglas P bought $0 and sold $3.7M based on SEC Form 4 filings.
What was Golwas Douglas P's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 100,000 MDLN shares on 2026-06-16, worth $3.7M, per SEC Form 4 filings.